Article (Scientific journals)
Le pimecrolimus topique (Elidel).
Quatresooz, Pascale; Fumal, I.; Pierard, Claudine et al.
2003In Revue Médicale de Liège, 58 (3), p. 168-71
Peer reviewed
 

Files


Full Text
PIMECROLIMUS ELIDEL.pdf
Publisher postprint (518.36 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Administration, Cutaneous; Calcineurin/antagonists & inhibitors; Dermatitis, Atopic/drug therapy; Dermatologic Agents/pharmacology/therapeutic use; Humans; Peptidylprolyl Isomerase/antagonists & inhibitors; Tacrolimus/analogs & derivatives/pharmacology/therapeutic use
Abstract :
[en] Pimecrolimus inhibits some specific steps of the Th1 and Th2 immune reactions. It belongs to the class of ascomycin macrolactams. The topical drug formulation targets cutaneous inflammation, more particularly lymphocytes and mast cells without impairing systemic immunosurveillance. Topical applications are indicated for treating atopic dermatitis. In this indication, it represents an alternative or an adjuvant drug to topical corticosteroids. The treatment of other dermatoses could also benefit from pimecrolimus.
Disciplines :
Dermatology
Author, co-author :
Quatresooz, Pascale  ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Fumal, I.;  Centre Hospitalier Régional de Huy > Dermatologie
Pierard, Claudine ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Pierard, Gérald ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
French
Title :
Le pimecrolimus topique (Elidel).
Alternative titles :
[en] Medication of the month. Topical pimecrolimus (Elidel).
Publication date :
2003
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
58
Issue :
3
Pages :
168-71
Peer reviewed :
Peer reviewed
Available on ORBi :
since 14 April 2009

Statistics


Number of views
65 (1 by ULiège)
Number of downloads
1 (0 by ULiège)

Scopus citations®
 
5
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi